Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Amikacin (500mg) Injection
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial
Packaging
1x2ml
Price
₹109/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Amikacin 500mg injection is a broad-spectrum aminoglycoside antibiotic formulation used for the effective management of serious bacterial infections.
It works by inhibiting bacterial protein synthesis, leading to rapid bacterial cell death and strong activity against resistant gram-negative pathogens.
This injection is commonly prescribed for septicemia, respiratory infections, urinary tract infections, and intra-abdominal infections, especially in hospital and intensive care settings.
With reliable potency, strong antibacterial action, and wide hospital usage, this formulation strengthens an antibiotic injectable portfolio and supports consistent demand in critical care treatment.
Common side effects may include pain at the injection site, nausea, or mild rash. Rarely, nephrotoxicity, ototoxicity (hearing impairment), or vestibular disturbances may occur, especially with prolonged use or high doses.
Mikatyle 500 Injection is indicated for the treatment of severe infections such as respiratory tract infections, urinary tract infections, septicemia, intra-abdominal infections, skin and soft tissue infections, and postoperative infections, as prescribed by a healthcare professional.
For parenteral use only and should be administered under strict medical supervision. Dose adjustment is required in renal impairment. Regular monitoring of kidney function and hearing is recommended during therapy.
Store in a cool, dry place below 25°C. Protect from direct sunlight. Keep out of reach of children.
Composition : Lactulose 15 ml contains lactulose concentrate 66.7% in 6 gm Syrup
Composition : Ayurvedic Constipation Syrup
Composition : Aceclofenac (200mg) + Rabeprazole (20mg) Capsule
Composition : Acotiamide (100mg) Tablet
Composition : Acotiamide (300mg) Tablet
Composition : Magaldrate I.P. 400mg + Simethicone I.P. 20mg (Mango & Mint Flavour)
Composition : Magaldrate I.P. 480mg + Simethicone I.P. 20mg + Oxetacaine B.P. 10mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Amikacin 500 Injection has strong demand in the hospital and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable antibiotic and anti-infective portfolios.
Medical distributors and agencies can benefit from consistent demand for treatment of serious bacterial infections including respiratory tract infections, urinary tract infections, sepsis, abdominal infections, and hospital-acquired infections. It is commonly used in hospitals, ICUs, and emergency care settings, strengthening a reliable injectable antibiotic portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Amikacin 500 Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, ICU and inpatient usage, steady institutional orders, reliable supply chain support, and good margins when partnering for this injectable antibiotic product.
Medical distributors, stockists, and wholesalers interested in Amikacin 500 Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.